SECOND EXTENSION - GRANTED
granted
on 02 Jul 2024
Last Applicant/ Owned by
280 Bishopsgate
London
GB
EC2M4RB
Serial Number
97491421 filed on 06th Jul 2022
Registration Number
N/A
Correspondent Address
Lindsay B. Allen
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ISOLABS
Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial int Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development and testing of computing methods, computer software algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research and technological consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology, and scientific research; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software applications for designing and developing artificial intelligence, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for software development in the fields of software for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97491421
Mark Type
No Service Mark
Attorney Docket Number
No 117014-4008.
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Jul 2024 | SOU EXTENSION 2 FILED |
| 02th Jul 2024 | SOU EXTENSION 2 GRANTED |
| 02th Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 02th Jul 2024 | SOU TEAS EXTENSION RECEIVED |
| 19th Apr 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 19th Apr 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 19th Apr 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 02th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Dec 2023 | SOU EXTENSION 1 GRANTED |
| 29th Dec 2023 | SOU EXTENSION 1 FILED |